-
1 Comment
Asymchem Laboratories (Tianjin) Co., Ltd is currently in a long term uptrend where the price is trading 17.6% above its 200 day moving average.
From a valuation standpoint, the stock is 156.5% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 24.7.
Asymchem Laboratories (Tianjin) Co., Ltd's total revenue rose by 25.8% to $817M since the same quarter in the previous year.
Its net income has increased by 38.9% to $191M since the same quarter in the previous year.
Finally, its free cash flow fell by 368.6% to $-90M since the same quarter in the previous year.
Based on the above factors, Asymchem Laboratories (Tianjin) Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Biotechnology |
| ISIN | CNE100002BZ6 |
| Market Cap | 23B |
|---|---|
| Beta | 0.26 |
| Target Price | 87.6011 |
| Dividend Yield | 2.7% |
| PE Ratio | 24.93 |
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions. In addition, the company is involved in development and drug product manufacturing; provision of pharmaceutical analysis and testing services; medical research and development; manufacturing, sale, and development of medicine raw materials and relevant products; sale of drug products; pharmaceuticals and chemical manufacturing; wholesaling and retailing of drugs; sale, import and export trade; information technology; technology development; and research and experimental development activities. The company was founded in 1998 and is headquartered in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002821.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
